A randomized, double-blind, placebo-controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease., PMID:39739628
Tofacitinib Regulates Endostatin via Effects on CD147 and Cathepsin S., PMID:39000375
Elevated Cathepsin S Serum Levels in New-Onset Type 1 Diabetes and Autoantibody-Positive Siblings., PMID:38701365
Correlation between SARS-CoV-2 infection and autoimmune rheumatic diseases: a comprehensive analysis of blood biomarkers in COVID-19 patients., PMID:38164875
Chest Computed Tomography Characteristics of Critically Ill COVID-19 Patients with Auto-antibodies Against Type I Interferons., PMID:38129345
Rational design of humanized antibody inhibitors for cathepsin S., PMID:38061628
Spinal Cathepsin S promotes visceral hypersensitivity via FKN/CX3CR1/p38 MAPK signaling pathways., PMID:37347150
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy., PMID:36921034
Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus., PMID:35157914
An Immunosensor for the Determination of Cathepsin S in Blood Plasma by Array SPRi-A Comparison of Analytical Properties of Silver-Gold and Pure Gold Chips., PMID:34562888
Overexpression of cathepsin S exacerbates lupus pathogenesis through upregulation TLR7 and IFN-α in transgenic mice., PMID:34381063
Transforming growth factor-β1 inhibits interleukin-1β-induced expression of inflammatory genes and Cathepsin S activity in human vascular smooth muscle cells., PMID:33683760
Two SPRi biosensors for the determination of cathepsin S in blood plasma., PMID:33592693
Extensive serum biomarker analysis before and after treatment in healing of diabetic foot ulcers using a cytokine antibody array., PMID:32585582
Leading the invasion: The role of Cathepsin S in the tumour microenvironment., PMID:32544418
Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse., PMID:32437743
B cells rapidly target antigen and surface-derived MHCII into peripheral degradative compartments., PMID:31780582
Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9., PMID:31438640
Multiple roles of Bet v 1 ligands in allergen stabilization and modulation of endosomal protease activity., PMID:31230350
Profile of neuronal exosomes in HIV cognitive impairment exposes sex differences., PMID:31149942
Targeting of cathepsin S reduces cystic fibrosis-like lung disease., PMID:30655278
NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis., PMID:30201519
Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model., PMID:30196110
Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens., PMID:29570395
Protective Effect of Human Leukocyte Antigen (HLA) Allele DRB1*13:02 on Age-Related Brain Gray Matter Volume Reduction in Healthy Women., PMID:29452862
Retinoic acid prevents immunogenicity of milk lipocalin Bos d 5 through binding to its immunodominant T-cell epitope., PMID:29371615
Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins., PMID:29100330
Two Distinct Conformations in Bet v 2 Determine Its Proteolytic Resistance to Cathepsin S., PMID:29035299
Granulocyte-colony-stimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis., PMID:28973941
Cathepsin-S degraded decorin are elevated in fibrotic lung disorders - development and biological validation of a new serum biomarker., PMID:28793886
Increased cathepsin S in Prdm1-/- dendritic cells alters the TFH cell repertoire and contributes to lupus., PMID:28692065
Multiplex Cathepsin Zymography to Detect Amounts of Active Cathepsins K, L, S, and V., PMID:28608217
Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer., PMID:28282545
Mechanisms and New Strategies for Primary Sjögren's Syndrome., PMID:28099084
REPLY: Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing., PMID:28003044
Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing., PMID:27956316
Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model., PMID:27687148
Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation., PMID:27595325
Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions., PMID:27135822
Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells., PMID:26960148
Recent advances in the field of anti-cancer immunotherapy., PMID:26673349
Rat-to-Chinese tree shrew heart transplantation is a novel small animal model to study non-Gal-mediated discordant xenograft humoral rejection., PMID:26589781
IL-1α and inflammasome-independent IL-1β promote neutrophil infiltration following alum vaccination., PMID:26536497
Autophagy Contributes to the Induction of Anti-TNF Induced Macrophages., PMID:26417049
CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner., PMID:26358505
Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies., PMID:26060322
Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer., PMID:25779848
Decreased expression of thymus-specific proteasome subunit β5t in Down syndrome patients., PMID:25556590
Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors., PMID:25446656
Tear cathepsin S as a candidate biomarker for Sjögren's syndrome., PMID:24644101
For research use only. Not for human or drug use.
